Company

2019: The Year of the Digital Pharma?

  • January, 08 2019
  • 701

Mergers and acquisitions (M&A) used to be the most disruptive force affecting pharma. Mega-deals continue: Takeda’s $59 billion deal for Shire in 2018, a record-breaker, has just been surpassed in early 2019 by Bristol Myers Squibb’s surprise $74 bill

Disease

‘Tis the Season to be Vaccinated

  • January, 08 2019
  • 230

The influenza season illustrates the value of preventative medicine, and how pricing dynamics and vaccination strategies can influence population health. Preventing ‘flu and the complications that can arise from ‘flu-related infections, especially

Related Videos
Oliver Spray Analyst
Oliver Spray Analyst

M&A Outlook for 2018

Amanda Mucklus Analyst
Amanda Mucklus Analyst

Diversification Strategy

Pharma Intelligence
Pharma Intelligence

Biosimilars Battlegrounds

Pharma Intelligence
Pharma Intelligence

Q4 2018 Outlook Webinar